Skip to main content
. 2020 Jun 6;25(11):2649. doi: 10.3390/molecules25112649

Figure 16.

Figure 16

(A) Cumulative ICG release and fluorescence recovery (drug release real time imaging) with or without hyaluronidase through release procedure. (B) Cellular uptake of nanoparticles after incubation for 4 and 12 h. The white bar represents 50 μm. (C) Cell viability measured by MTT assays. (D) Nanoparticles penetrating into tumor spheroids. The white bar represents 200 μm, a—represents AuNC@CBSA-ICG, b—represents AuNC@CBSA-ICG@HA and c—represents AuNC@CBSA-ICG@HA pretreated with hyaluronidase. (E) The in vitro photothermal effect of formulations measured by calcein-AM/PI double staining. The white bar represents 200 μm. From [113].